Arkolith/Insider Trading/OBIO/Form 4

Hochman David P

See Remarks, DirectorOrchestra BioMed Holdings, Inc. (OBIO) · full profile →Form 4 · filed Sep 26, 2024
Net Buying
Open-Market Buys
$48K
Open-Market Sells
$0
Net Open-Market Flow
$48K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2024Buy(P)2K$4.73$9K2K
Sep 25, 2024Buy(P)2K$4.70$9K2K
Sep 25, 2024Buy(P)2K$4.74$9K2K
Sep 25, 2024Buy(P)2K$4.86$7K335K
Sep 24, 2024Buy(P)3K$4.91$12K570K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-103002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML